Moderate riskFDA DrugClass II

Major Pharmaceuticals levothyroxine 75 mcg tablets recalled for subpotent drug

Major Pharmaceuticals is recalling certain lots of Levothyroxine Sodium Tablets, USP, 75 mcg because they may contain less active ingredient than labeled. Patients taking affected tablets may not receive the full intended dose of this thyroid hormone medication.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if your levothyroxine bottle matches lot N02172 (exp. 07/2026) or N02296/N02288 (exp. 12/2026), NDC 0904-6951-61
  2. Contact your pharmacy or prescriber if you have one of the affected lots
  3. Do not stop taking your medication without talking to your doctor
  4. Your doctor may need to check your thyroid levels

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 12 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Classification
Class II
Recall number
D-0702-2026

In the FDA's words

Description
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61 Subpotent Drug Lot# N02172, exp 07/2026; N02296, N02288, Exp. Date 12/2026 Distribution: Nationwide in the USA. Affected quantity: N/A
Hazard
Subpotent Drug

12 products in this recall

The agency lists each product separately. Check every one you might have.

Related topics

PotencyDrugsSold nationwideMore from FDA Drug